Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 21, 2020
Finance

HotSpot heads for clinic with $65M series B round to develop allosteric modulators

With strategics, one crossover on board, HotSpot is likely to raise mezzanine round before exploring IPO
BioCentury | Jul 17, 2018
Product R&D

Natural spots

HotSpot Therapeutics’ small molecules take a page from natural allostery
BioCentury | Sep 11, 2017
Distillery Therapeutics

Neurology

BioCentury | Feb 23, 2017
Translation in Brief

No problem, Houston

EMD Serono taps MD Anderson's APOLLO platform for high-standard biopsy studies
BioCentury | Mar 24, 2016
Strategy

Combo platter

How Incyte aims to discover high synergy combo therapies
Items per page:
1 - 10 of 11